Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 17.60M | £ 51.30M | £ 9.20M | £ 45.70M | £ 31.40M |
Total Assets | £ 676.70M | £ 542.90M | £ 503.80M | £ 534.50M | £ 527.20M |
Total Debt | £ 82.40M | £ 9.50M | £ 10.90M | £ 35.10M | £ 95.30M |
Net Debt | £ 64.80M | £ -41.80M | £ 1.70M | £ -10.60M | £ 63.90M |
Total Liabilities | £ 153.70M | £ 70.40M | £ 68.10M | £ 75.80M | £ 146.60M |
Stockholders Equity | £ 523.00M | £ 472.50M | £ 435.70M | £ 458.70M | £ 380.60M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |